EP4376832

OBICETRAPIB FOR USE IN TREATING OF CARDIOVASCULAR DISEASE (CVD) IN HIS HYPORESPONDERS

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    25.7.2022
  • EP published:
    25.3.2026
  • EP application number:
    22754412.9
  • Max expiry date:
    24.7.2042
  • Expiry date:
    24.7.2026
  • Title in English:
    OBICETRAPIB FOR USE IN TREATING OF CARDIOVASCULAR DISEASE (CVD) IN HIS HYPORESPONDERS
  • Language of the patent:
    English

Timeline

Today
25.7.2022EP application
25.3.2026EP Publication
24.7.2026Expires

Owner

  • Name:
    NewAmsterdam Pharma B.V.
  • Address:
    Gooimeer 2-35, 1411 DC Naarden, NL

Inventor

  • Name:
    KASTELEIN, Johannes Jacob Pieter
  • Address:
    1411 DC Naarden, NL
  • Name:
    DITMARSCH, Marc
  • Address:
    1411 DC Naarden, NL
  • Name:
    DAVIDSON, Michael Harvey
  • Address:
    1411 DC Naarden, NL

Priority

  • Number:
    21187721
  • Date:
    26.7.2021
  • Country:
    EP

Classification

  • Categories:
    A61K 31/40, A61K 31/505, A61K 31/506, A61P 3/06

Upload documents